Suppr超能文献

复方口服避孕药引起的神经活性甾体降低与情绪变化无关。

Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes.

作者信息

Rapkin Andrea J, Morgan Melinda, Sogliano Cristiana, Biggio Giovanni, Concas Alessandra

机构信息

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095-1740, USA.

出版信息

Fertil Steril. 2006 May;85(5):1371-8. doi: 10.1016/j.fertnstert.2005.10.031. Epub 2006 Apr 3.

Abstract

OBJECTIVE

To evaluate the effects of a low-dose combined oral contraceptive pill (OCP) on peripheral neuroactive steroid concentrations, precursors for neuroactive steroid synthesis, and mood in healthy women desiring contraception. These neuroactive steroids are gamma-aminobutyric acid receptor agonists and are important in the modulation of affect and adaptation to stress.

DESIGN

Prospective observational study.

SETTING

Human ambulatory patient study.

PATIENT(S): Healthy OCP-naive women without current or history of affective disorder.

INTERVENTION(S): A 0.020-mg ethinyl E2-0.1-mg levonorgestrel containing OCP for 3 months.

MAIN OUTCOME MEASURE(S): Serum neuroactive steroids allopregnanolone, allotetrahydrodeoxycorticosterone, and DHEA; neuroactive steroid precursors P and pregnenolone; E2; and mood and anxiety as assessed by the Premenstrual Syndrome Daily Ratings Form, Beck Depression Inventory, Spielberger State-Trait Anxiety Inventory, and Profile of Mood States.

RESULT(S): The combined OCP resulted in a decrease in neuroactive steroids and neuroactive steroid precursors as well as in E2. However, this decline was not associated with adverse mood changes on any of the well-validated assessment tools.

CONCLUSION(S): Healthy women without underlying mood or anxiety disorder who were given a low-dose OCP did not experience adverse psychological symptoms despite a significant reduction in neuroactive steroids.

摘要

目的

评估低剂量复方口服避孕药(OCP)对希望避孕的健康女性外周神经活性甾体浓度、神经活性甾体合成前体及情绪的影响。这些神经活性甾体是γ-氨基丁酸受体激动剂,在情感调节和应激适应中起重要作用。

设计

前瞻性观察性研究。

地点

人类门诊患者研究。

患者

无情感障碍病史及当前发作的未服用过OCP的健康女性。

干预措施

服用含0.020mg炔雌醇和0.1mg左炔诺孕酮的OCP,为期3个月。

主要观察指标

血清神经活性甾体别孕烷醇酮、别四氢脱氧皮质酮和脱氢表雄酮;神经活性甾体前体P和孕烯醇酮;雌二醇;以及通过经前综合征每日评分表、贝克抑郁量表、斯皮尔伯格状态-特质焦虑量表和情绪状态剖面图评估的情绪和焦虑。

结果

复方OCP导致神经活性甾体、神经活性甾体前体以及雌二醇水平降低。然而,在任何经过充分验证的评估工具上,这种下降均未伴随不良情绪变化。

结论

在未患潜在情绪或焦虑障碍的健康女性中,给予低剂量OCP后,尽管神经活性甾体显著减少,但未出现不良心理症状。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验